
Trending News Today: New Flu Drug Shows Potential, But Also Raises Concerns
Top news of the day from across the health care landscape.
GlaxoSmithKline (GSK) announced that the FDA sent a complete response letter (CRL) regarding its application for mepolizumab (Nucala) as an add-on treatment to inhaled corticosteroid-based maintenance treatment for chronic obstructive pulmonary disease (COPD),
An investigational flu drug has shown promising results in clinical trials but some data raise concerns,
A new study found that more than 1 in 9 individuals worldwide who were eligible for HIV pre-exposure prophylaxis (PrEP) are taking the drug,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.